Milestone Gross Profit from 2010 to 2025

MLSS Stock

USD 1.07 0.06 5.94%

Milestone Scientific Gross Profit yearly trend continues to be comparatively stable with very little volatility. Gross Profit will likely drop to about 4.5 M in 2025. Gross Profit is the profit Milestone Scientific makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

1996-06-30

Previous Quarter

1.4 M

Current Value

1.8 M

Quarterly Volatility

818.4 K

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Milestone Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Milestone Scientific's main balance sheet or income statement drivers, such as Depreciation And Amortization of 164.7 K, Interest Expense of 59.7 K or Selling General Administrative of 8.5 M, as well as many indicators such as Price To Sales Ratio of 5.58, Dividend Yield of 0.0 or PTB Ratio of 6.85. Milestone financial statements analysis is a perfect complement when working with Milestone Scientific Valuation or Volatility modules.

Check out the analysis of Milestone Scientific Correlation against competitors.

For more information on how to buy Milestone Stock please use our How to Invest in Milestone Scientific guide.

Latest Milestone Scientific's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Milestone Scientific over the last few years. Gross profit is a required income statement account that reflects total revenue of Milestone Scientific minus its cost of goods sold. It is profit before Milestone Scientific operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Milestone Scientific's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Milestone Scientific's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 6.43 M

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Gross Profit

Timeline

Milestone Gross Profit Regression Statistics

	Arithmetic Mean	5,538,384
	Geometric Mean	4,800,378
	Coefficient Of Variation	32.16
	Mean Deviation	1,259,598
	Median	6,306,472
	Standard Deviation	1,781,147
	Sample Variance	3.2T
	Range	7.5M
	R-Value	0.28
	Mean Square Error	3.1T
	R-Squared	0.08
	Significance	0.30
	Slope	103,358
	Total Sum of Squares	47.6T

Milestone Gross Profit History

	2025	4.5 M
	2024	7.8 M
	2023	6.8 M
	2022	4.9 M
	2021	6.3 M
	2020	3.6 M
	2019	5.7 M

Other Fundumenentals of Milestone Scientific

Gross Profit Margin

Milestone Scientific Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Total Permanent Equity	Long Term Debt Total	Capital Surpluse	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.95	-0.88	-0.45	-0.36	0.17	0.14	0.98	-0.03	-0.09	0.38	0.04	0.53	0.32	0.71	0.67	0.03	0.56	0.45	0.72	0.71	0.37
Total Stockholder Equity	0.95		-0.93	-0.34	-0.42	-0.06	-0.19	0.94	-0.18	-0.2	0.35	0.04	0.6	0.1	0.74	0.61	0.03	0.53	0.32	0.78	0.77	0.4
Net Debt	-0.88	-0.93		0.37	0.46	0.08	0.16	-0.88	0.18	0.26	-0.34	-0.15	-0.57	0.01	-0.62	-0.55	0.13	-0.51	-0.29	-0.76	-0.77	-0.36
Retained Earnings	-0.45	-0.34	0.37		0.23	0.15	-0.33	-0.56	0.07	0.59	-0.87	0.33	-0.62	-0.11	-0.68	-0.47	-0.37	-0.84	-0.72	-0.32	-0.44	-0.79
Accounts Payable	-0.36	-0.42	0.46	0.23		0.18	0.22	-0.41	0.12	-0.13	-0.42	0.06	-0.55	-0.23	-0.4	-0.33	-0.09	-0.54	-0.4	-0.31	-0.38	-0.43
Net Receivables	0.17	-0.06	0.08	0.15	0.18		0.72	0.12	0.67	0.53	-0.42	0.39	-0.55	0.74	-0.37	0.24	-0.37	-0.29	0.21	-0.34	-0.4	-0.6
Total Liab	0.14	-0.19	0.16	-0.33	0.22	0.72		0.11	0.53	0.3	0.09	0.02	-0.21	0.7	-0.12	0.17	0.0	0.09	0.46	-0.21	-0.2	-0.11
Total Current Assets	0.98	0.94	-0.88	-0.56	-0.41	0.12	0.11		0.0	-0.23	0.48	0.01	0.59	0.29	0.74	0.75	0.08	0.67	0.58	0.66	0.69	0.46
Short Term Debt	-0.03	-0.18	0.18	0.07	0.12	0.67	0.53	0.0		0.27	-0.28	0.25	-0.31	0.56	-0.34	0.16	-0.24	-0.18	0.35	-0.34	-0.36	-0.45
Intangible Assets	-0.09	-0.2	0.26	0.59	-0.13	0.53	0.3	-0.23	0.27		-0.52	0.28	-0.36	0.6	-0.43	-0.23	-0.29	-0.44	-0.19	-0.18	-0.28	-0.53
Common Stock	0.38	0.35	-0.34	-0.87	-0.42	-0.42	0.09	0.48	-0.28	-0.52		-0.63	0.82	0.05	0.8	0.37	0.63	0.87	0.63	0.43	0.56	0.94
Treasury Stock	0.04	0.04	-0.15	0.33	0.06	0.39	0.02	0.01	0.25	0.28	-0.63		-0.39	0.0	-0.52	-0.09	-0.92	-0.29	-0.12	-0.12	-0.18	-0.53
Property Plant Equipment	0.53	0.6	-0.57	-0.62	-0.55	-0.55	-0.21	0.59	-0.31	-0.36	0.82	-0.39		-0.02	0.84	0.26	0.39	0.8	0.51	0.75	0.83	0.87
Current Deferred Revenue	0.32	0.1	0.01	-0.11	-0.23	0.74	0.7	0.29	0.56	0.6	0.05	0.0	-0.02		0.07	0.35	0.0	0.09	0.54	-0.09	-0.11	-0.13
Net Tangible Assets	0.71	0.74	-0.62	-0.68	-0.4	-0.37	-0.12	0.74	-0.34	-0.43	0.8	-0.52	0.84	0.07		0.57	0.53	0.74	0.43	0.67	0.72	0.8
Total Permanent Equity	0.67	0.61	-0.55	-0.47	-0.33	0.24	0.17	0.75	0.16	-0.23	0.37	-0.09	0.26	0.35	0.57		0.16	0.49	0.55	0.07	0.12	0.27
Long Term Debt Total	0.03	0.03	0.13	-0.37	-0.09	-0.37	0.0	0.08	-0.24	-0.29	0.63	-0.92	0.39	0.0	0.53	0.16		0.45	0.24	0.12	0.18	0.61
Capital Surpluse	0.56	0.53	-0.51	-0.84	-0.54	-0.29	0.09	0.67	-0.18	-0.44	0.87	-0.29	0.8	0.09	0.74	0.49	0.45		0.78	0.48	0.6	0.91
Short Long Term Debt	0.45	0.32	-0.29	-0.72	-0.4	0.21	0.46	0.58	0.35	-0.19	0.63	-0.12	0.51	0.54	0.43	0.55	0.24	0.78		0.15	0.26	0.54
Net Invested Capital	0.72	0.78	-0.76	-0.32	-0.31	-0.34	-0.21	0.66	-0.34	-0.18	0.43	-0.12	0.75	-0.09	0.67	0.07	0.12	0.48	0.15		0.99	0.52
Net Working Capital	0.71	0.77	-0.77	-0.44	-0.38	-0.4	-0.2	0.69	-0.36	-0.28	0.56	-0.18	0.83	-0.11	0.72	0.12	0.18	0.6	0.26	0.99		0.64
Capital Stock	0.37	0.4	-0.36	-0.79	-0.43	-0.6	-0.11	0.46	-0.45	-0.53	0.94	-0.53	0.87	-0.13	0.8	0.27	0.61	0.91	0.54	0.52	0.64

Click cells to compare fundamentals

About Milestone Scientific Financial Statements

Milestone Scientific shareholders use historical fundamental indicators, such as Gross Profit, to determine how well the company is positioned to perform in the future. Although Milestone Scientific investors may analyze each financial statement separately, they are all interrelated. The changes in Milestone Scientific's assets and liabilities, for example, are also reflected in the revenues and expenses on on Milestone Scientific's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Gross Profit	7.8 M	4.5 M
Gross Profit Margin	0.62	0.45

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Milestone Stock Analysis

When running Milestone Scientific's price analysis, check to measure Milestone Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Scientific is operating at the current time. Most of Milestone Scientific's value examination focuses on studying past and present price action to predict the probability of Milestone Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Scientific's price. Additionally, you may evaluate how the addition of Milestone Scientific to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC